• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi participates in the 2nd International Conference on Public Health in Africa

Home > News

DNDi participates in the 2nd International Conference on Public Health in Africa

Group photo of panelists of the CPHIA NTD Side event
From left to right: Tony Ukety, ophthalmologist & NTD expert; Philipp Frisch, Médecins Sans Frontières; Neneh Sallah, Youth Combating NTDs; John Amuasi, African Research Network for Neglected Tropical Diseases (ARNTD); Damaris Matoke-Muhia, KEMRI; Sahar Bakheit, Mycetoma Research Centre; Simon Bolo, DNDi
19 Dec 2022

The Drugs for Neglected Diseases initiative (DNDi) participated in the 2nd International Conference on Public Health in Africa (CPHIA) that was held in Kigali, Rwanda on 13-15 December 2022. The conference, which was organized by the Africa Centres for Disease Control and Prevention (Africa CDC) and African Union in collaboration with the Government of Rwanda, brought together over 2,500 in-person participants plus additional participants online. Participants came from 90 countries all over the globe with 87% of all participants from Africa.  

‘Africa has a wealth of knowledge to respond to its own needs. This conference is by Africans for everyone, a platform for Africans to solve challenges around the world and guide solutions to benefit global health security. Excellent science will always be the foundation of strong public health,’ said Dr Ahmed Ogwell Ouma, Acting Director, Africa CDC. 

DNDi participated in and organized a number of sessions. This included hosting the only side event at the conference on neglected tropical diseases (NTDs) titled NTDs in Africa: Why we must innovate and act now. 

The panel emphasized the importance of innovative tools for disease surveillance and proper diagnosis, and the importance of government involvement in the treatment of NTDs. The place of the youth as drivers of innovation to tackle NTDs was highlighted as one of the key components in eliminating NTDs on the African continent.  

‘Innovation in tackling NTDs needs to be at the forefront of all African health systems. There must be sustained commitment from governments, funding agencies, and the research community to address the needs of neglected patients. It’s time for Africa to take ownership and responsibility for the health of our citizens. We must own our story,’ said Dr Monique Wasunna, Eastern Africa Director. 

Watch the recording:

DNDi also supported the COVID-19 Clinical Research Coalition side event and Pandemic Preparedness Platform for Health and Emerging infections’ Response (PANTHER) side event focusing on the response to the COVID-19 pandemic. The COVID- 19 Clinical Research Coalition discussions focused on harnessing the strength of collaboration and lessons learned from the COVID-19 pandemic focusing on low- and middle-income countries.  

The PANTHER event launched this new platform that brings together leading African and global researchers and public health teams to help countries and communities better prepare before emerging infectious diseases become pandemics.  

CPHIA was a unique opportunity for African researchers, policy makers, academia, civil society, and other stakeholders to discuss health solutions for the African continent by Africans. 

Pandemic Preparedness Africa

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License